Valeo Pharma Inc logo

Valeo Pharma Inc

0
FRA:VP2 (Canada)   Ordinary Shares
€ 0.01 (0%) Nov 8
At Loss
Market Cap:
€ 2.97M ($ 3.16M)
Enterprise V:
€ 45.02M ($ 47.96M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.1
Equity-to-Asset -1.96
Debt-to-Equity -1.11
Debt-to-EBITDA -4.98
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.5
Distress
Grey
Safe
Beneish M-Score -6.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 37.63
9-Day RSI 41.58
14-Day RSI 43.52
6-1 Month Momentum % -87.18
12-1 Month Momentum % -94.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.27
Quick Ratio 0.2
Cash Ratio 0.1
Days Inventory 74.86
Days Sales Outstanding 36.04
Days Payable 71.62

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.5
Shareholder Yield % -110.6

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 18.94
Operating Margin % -34.61
Net Margin % -60.18
FCF Margin % -17.08
ROA % -82.84
ROIC % -43.99
3-Year ROIIC % -67.67
ROC (Joel Greenblatt) % -475.41

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.08
EV-to-EBIT -4.03
EV-to-EBITDA -4.79
EV-to-Revenue 1.26
EV-to-Forward-Revenue 0.97
EV-to-FCF -7.47
Earnings Yield (Greenblatt) % -24.81
FCF Yield % -203.2

Financials

FRA:VP2's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Valeo Pharma Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 36.414
EPS (TTM) (€) -0.233
Beta 1.42
Volatility % 153.53
14-Day RSI 43.52
14-Day ATR (€) 0.001212
20-Day SMA (€) 0.005
12-1 Month Momentum % -94.62
52-Week Range (€) 0.0045 - 0.226
Shares Outstanding (Mil) 98.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Valeo Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

Valeo Pharma Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Valeo Pharma Inc Frequently Asked Questions

What is Valeo Pharma Inc(FRA:VP2)'s stock price today?
The current price of FRA:VP2 is €0.01. The 52 week high of FRA:VP2 is €0.23 and 52 week low is €0.00.
When is next earnings date of Valeo Pharma Inc(FRA:VP2)?
The next earnings date of Valeo Pharma Inc(FRA:VP2) is .
Does Valeo Pharma Inc(FRA:VP2) pay dividends? If so, how much?
Valeo Pharma Inc(FRA:VP2) does not pay dividend.

Press Release

Subject Date
No Press Release